

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.86394087 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.86394087 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 5.86394087 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 5.86394087 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 5.86394087 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.86394087 |
| 7 | response to peptidoglycan (GO:0032494) | 5.35349374 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 5.19948622 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.15160877 |
| 10 | immunoglobulin mediated immune response (GO:0016064) | 5.05473647 |
| 11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.90159352 |
| 12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.90159352 |
| 13 | detection of other organism (GO:0098543) | 4.89441603 |
| 14 | respiratory burst (GO:0045730) | 4.87106819 |
| 15 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.73704262 |
| 16 | detection of bacterium (GO:0016045) | 4.73612487 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.61854682 |
| 18 | macrophage activation involved in immune response (GO:0002281) | 4.49597766 |
| 19 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.44255473 |
| 20 | detection of external biotic stimulus (GO:0098581) | 4.20070010 |
| 21 | neutrophil mediated immunity (GO:0002446) | 4.17844252 |
| 22 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.16414775 |
| 23 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.14774633 |
| 24 | response to host immune response (GO:0052572) | 4.14429515 |
| 25 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.14429515 |
| 26 | detection of molecule of bacterial origin (GO:0032490) | 4.05670675 |
| 27 | positive regulation of B cell differentiation (GO:0045579) | 4.04637771 |
| 28 | positive regulation of interferon-alpha production (GO:0032727) | 3.94252408 |
| 29 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.92810022 |
| 30 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.89176917 |
| 31 | regulation of gamma-delta T cell activation (GO:0046643) | 3.85350159 |
| 32 | B cell mediated immunity (GO:0019724) | 3.83747552 |
| 33 | positive regulation of antigen processing and presentation (GO:0002579) | 3.83316799 |
| 34 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.82322046 |
| 35 | neutrophil activation (GO:0042119) | 3.81855194 |
| 36 | response to host (GO:0075136) | 3.80726298 |
| 37 | response to host defenses (GO:0052200) | 3.80726298 |
| 38 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.80726298 |
| 39 | response to muramyl dipeptide (GO:0032495) | 3.79273296 |
| 40 | negative regulation of phagocytosis (GO:0050765) | 3.77178270 |
| 41 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.76040658 |
| 42 | regulation of interferon-alpha production (GO:0032647) | 3.75818311 |
| 43 | cellular extravasation (GO:0045123) | 3.75180707 |
| 44 | granulocyte activation (GO:0036230) | 3.72041596 |
| 45 | detection of biotic stimulus (GO:0009595) | 3.71094292 |
| 46 | leukocyte aggregation (GO:0070486) | 3.65393800 |
| 47 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.63111989 |
| 48 | response to fungus (GO:0009620) | 3.60959794 |
| 49 | myeloid cell activation involved in immune response (GO:0002275) | 3.60769530 |
| 50 | regulation of mast cell degranulation (GO:0043304) | 3.55658359 |
| 51 | regulation of B cell differentiation (GO:0045577) | 3.51896969 |
| 52 | negative regulation of interleukin-12 production (GO:0032695) | 3.49655236 |
| 53 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.48085588 |
| 54 | defense response to protozoan (GO:0042832) | 3.46897300 |
| 55 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.36802111 |
| 56 | positive regulation of mast cell activation (GO:0033005) | 3.36655357 |
| 57 | regulation of mast cell activation (GO:0033003) | 3.36482365 |
| 58 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.33085041 |
| 59 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.30055650 |
| 60 | regulation of antigen processing and presentation (GO:0002577) | 3.29680843 |
| 61 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.29339052 |
| 62 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.27612983 |
| 63 | response to interferon-beta (GO:0035456) | 3.26190125 |
| 64 | negative regulation of T cell mediated immunity (GO:0002710) | 3.26152786 |
| 65 | myeloid leukocyte mediated immunity (GO:0002444) | 3.25934308 |
| 66 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.23937063 |
| 67 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.23062428 |
| 68 | negative regulation of granulocyte differentiation (GO:0030853) | 3.21848074 |
| 69 | microglial cell activation (GO:0001774) | 3.21469036 |
| 70 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.21159562 |
| 71 | B cell receptor signaling pathway (GO:0050853) | 3.19789481 |
| 72 | regulation of T cell tolerance induction (GO:0002664) | 3.19256371 |
| 73 | response to protozoan (GO:0001562) | 3.18423936 |
| 74 | type I interferon signaling pathway (GO:0060337) | 3.17662298 |
| 75 | cellular response to type I interferon (GO:0071357) | 3.17662298 |
| 76 | leukocyte mediated cytotoxicity (GO:0001909) | 3.16828207 |
| 77 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.16381819 |
| 78 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.16343558 |
| 79 | response to type I interferon (GO:0034340) | 3.15371867 |
| 80 | regulation of regulated secretory pathway (GO:1903305) | 3.13630690 |
| 81 | pinocytosis (GO:0006907) | 3.13617750 |
| 82 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.11937656 |
| 83 | reactive oxygen species biosynthetic process (GO:1903409) | 3.11925329 |
| 84 | defense response to fungus (GO:0050832) | 3.11617533 |
| 85 | actin nucleation (GO:0045010) | 3.10661684 |
| 86 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.10655174 |
| 87 | regulation of tolerance induction (GO:0002643) | 3.09954299 |
| 88 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.07646988 |
| 89 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.07007799 |
| 90 | positive regulation of mast cell degranulation (GO:0043306) | 3.07007799 |
| 91 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.05757510 |
| 92 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.04748209 |
| 93 | response to interleukin-15 (GO:0070672) | 3.04063213 |
| 94 | cellular response to zinc ion (GO:0071294) | 3.01315277 |
| 95 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.00973422 |
| 96 | macrophage activation (GO:0042116) | 3.00944400 |
| 97 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.99891036 |
| 98 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.99891036 |
| 99 | negative regulation of interleukin-6 production (GO:0032715) | 2.98142636 |
| 100 | positive regulation of interferon-beta production (GO:0032728) | 2.97539674 |
| 101 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.97455296 |
| 102 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.97455296 |
| 103 | regulation of growth of symbiont in host (GO:0044126) | 2.97455296 |
| 104 | negative regulation of growth of symbiont in host (GO:0044130) | 2.97455296 |
| 105 | regulation of leukocyte degranulation (GO:0043300) | 2.93587650 |
| 106 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.92473024 |
| 107 | cellular response to interferon-beta (GO:0035458) | 2.91837292 |
| 108 | neutrophil chemotaxis (GO:0030593) | 2.91239851 |
| 109 | response to interferon-alpha (GO:0035455) | 2.90527429 |
| 110 | T-helper 1 type immune response (GO:0042088) | 2.90483584 |
| 111 | mature B cell differentiation (GO:0002335) | 2.88939891 |
| 112 | NIK/NF-kappaB signaling (GO:0038061) | 2.87289349 |
| 113 | positive regulation of leukocyte degranulation (GO:0043302) | 2.86808790 |
| 114 | negative regulation of innate immune response (GO:0045824) | 2.86158437 |
| 115 | leukotriene metabolic process (GO:0006691) | 2.85480241 |
| 116 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.84995441 |
| 117 | superoxide anion generation (GO:0042554) | 2.83307621 |
| 118 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.82883651 |
| 119 | negative regulation of cell killing (GO:0031342) | 2.82883651 |
| 120 | neutrophil migration (GO:1990266) | 2.82687170 |
| 121 | * myeloid leukocyte activation (GO:0002274) | 2.81540473 |
| 122 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.80368348 |
| 123 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.80001309 |
| 124 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.79439236 |
| 125 | germinal center formation (GO:0002467) | 2.78630947 |
| 126 | leukocyte degranulation (GO:0043299) | 2.75732082 |
| 127 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.75581683 |
| 128 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.74067265 |
| 129 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.72144223 |
| 130 | mature B cell differentiation involved in immune response (GO:0002313) | 2.71918490 |
| 131 | leukocyte mediated immunity (GO:0002443) | 2.70819772 |
| 132 | pentose-phosphate shunt (GO:0006098) | 2.70105629 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.97257115 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.75332327 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.86603077 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.73713349 |
| 5 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.44280818 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.44273734 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.41627523 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.35198138 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.16769687 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.16649557 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.13469716 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.92927224 |
| 13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.89600149 |
| 14 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.82760304 |
| 15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.69444040 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.67651960 |
| 17 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.64522955 |
| 18 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.56495723 |
| 19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.49881209 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.48455913 |
| 21 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.46247251 |
| 22 | MYC_22102868_ChIP-Seq_BL_Human | 2.32411485 |
| 23 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.29090733 |
| 24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.18868372 |
| 25 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.14581931 |
| 26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14372582 |
| 27 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.10653828 |
| 28 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.10143857 |
| 29 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.03684149 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 1.98874484 |
| 31 | MYB_26560356_Chip-Seq_TH2_Human | 1.94190182 |
| 32 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.92125601 |
| 33 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.90765113 |
| 34 | SPI1_23127762_ChIP-Seq_K562_Human | 1.86423720 |
| 35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86230714 |
| 36 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83735412 |
| 37 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81552956 |
| 38 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.79288557 |
| 39 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.72512525 |
| 40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.71088817 |
| 41 | UTX_26944678_Chip-Seq_JUKART_Human | 1.68711392 |
| 42 | MYB_26560356_Chip-Seq_TH1_Human | 1.68482548 |
| 43 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.68320669 |
| 44 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.66899137 |
| 45 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.66082551 |
| 46 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.61504981 |
| 47 | GATA1_22025678_ChIP-Seq_K562_Human | 1.60519042 |
| 48 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.53457310 |
| 49 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.51723105 |
| 50 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.51048740 |
| 51 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.50104462 |
| 52 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.49615917 |
| 53 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.46451545 |
| 54 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.46196190 |
| 55 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.45066216 |
| 56 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43948705 |
| 57 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42906087 |
| 58 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.40974041 |
| 59 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.40920667 |
| 60 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.38810819 |
| 61 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.32101555 |
| 62 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.31442273 |
| 63 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.28832445 |
| 64 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26907789 |
| 65 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25937411 |
| 66 | MAF_26560356_Chip-Seq_TH2_Human | 1.24301582 |
| 67 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23039007 |
| 68 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.22348950 |
| 69 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20849452 |
| 70 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17922593 |
| 71 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.17103218 |
| 72 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.16733568 |
| 73 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16707972 |
| 74 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.16123964 |
| 75 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.15374919 |
| 76 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.14848200 |
| 77 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14309874 |
| 78 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.12756331 |
| 79 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.10459945 |
| 80 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10198323 |
| 81 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.09818111 |
| 82 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09724496 |
| 83 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07659162 |
| 84 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07519873 |
| 85 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.07276529 |
| 86 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.05799824 |
| 87 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.05114906 |
| 88 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04490543 |
| 89 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03115463 |
| 90 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.00037446 |
| 91 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99967757 |
| 92 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.99885821 |
| 93 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.98035870 |
| 94 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.97903272 |
| 95 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.97800247 |
| 96 | GATA3_26560356_Chip-Seq_TH2_Human | 0.97506581 |
| 97 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.96529921 |
| 98 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.94853854 |
| 99 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.94009014 |
| 100 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93731691 |
| 101 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.93085521 |
| 102 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93082511 |
| 103 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.91973695 |
| 104 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.91701162 |
| 105 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90612446 |
| 106 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.89145712 |
| 107 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.89018445 |
| 108 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.88191212 |
| 109 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.87892311 |
| 110 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.86119580 |
| 111 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.83874250 |
| 112 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.83409045 |
| 113 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.82804130 |
| 114 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.77606050 |
| 115 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.75049110 |
| 116 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74978370 |
| 117 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.74464242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.20153392 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.10648332 |
| 3 | MP0003436_decreased_susceptibility_to | 3.78969615 |
| 4 | MP0009785_altered_susceptibility_to | 3.22617902 |
| 5 | MP0002419_abnormal_innate_immunity | 3.16462128 |
| 6 | MP0005058_abnormal_lysosome_morphology | 2.93033419 |
| 7 | MP0000685_abnormal_immune_system | 2.87270075 |
| 8 | MP0005025_abnormal_response_to | 2.86800832 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.83924327 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.81453238 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.67161905 |
| 12 | MP0001790_abnormal_immune_system | 2.65042287 |
| 13 | MP0005387_immune_system_phenotype | 2.65042287 |
| 14 | MP0001800_abnormal_humoral_immune | 2.64281746 |
| 15 | MP0005464_abnormal_platelet_physiology | 2.53710310 |
| 16 | MP0002723_abnormal_immune_serum | 2.45502970 |
| 17 | MP0003172_abnormal_lysosome_physiology | 2.42440058 |
| 18 | MP0005671_abnormal_response_to | 2.41263296 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.36970978 |
| 20 | MP0001819_abnormal_immune_cell | 2.36761166 |
| 21 | MP0006082_CNS_inflammation | 2.25787981 |
| 22 | MP0003724_increased_susceptibility_to | 2.20361959 |
| 23 | MP0002396_abnormal_hematopoietic_system | 2.19544271 |
| 24 | MP0009278_abnormal_bone_marrow | 2.18039954 |
| 25 | MP0001853_heart_inflammation | 2.16282588 |
| 26 | MP0004510_myositis | 2.15113111 |
| 27 | MP0002405_respiratory_system_inflammati | 2.01662301 |
| 28 | MP0001545_abnormal_hematopoietic_system | 2.00180136 |
| 29 | MP0005397_hematopoietic_system_phenotyp | 2.00180136 |
| 30 | MP0009840_abnormal_foam_cell | 1.99470159 |
| 31 | MP0001533_abnormal_skeleton_physiology | 1.99418843 |
| 32 | MP0002398_abnormal_bone_marrow | 1.93627884 |
| 33 | MP0003191_abnormal_cellular_cholesterol | 1.89248924 |
| 34 | MP0000716_abnormal_immune_system | 1.88955217 |
| 35 | MP0003300_gastrointestinal_ulcer | 1.88861770 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.85063606 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.77190274 |
| 38 | MP0005174_abnormal_tail_pigmentation | 1.75526742 |
| 39 | MP0000343_altered_response_to | 1.75111455 |
| 40 | MP0003183_abnormal_peptide_metabolism | 1.72369580 |
| 41 | MP0000465_gastrointestinal_hemorrhage | 1.71988735 |
| 42 | MP0009333_abnormal_splenocyte_physiolog | 1.70572420 |
| 43 | MP0010155_abnormal_intestine_physiology | 1.67490673 |
| 44 | MP0002429_abnormal_blood_cell | 1.63130345 |
| 45 | MP0004808_abnormal_hematopoietic_stem | 1.62701721 |
| 46 | MP0008469_abnormal_protein_level | 1.62337728 |
| 47 | MP0002166_altered_tumor_susceptibility | 1.60834794 |
| 48 | MP0004947_skin_inflammation | 1.60179650 |
| 49 | MP0002722_abnormal_immune_system | 1.59763177 |
| 50 | MP0005451_abnormal_body_composition | 1.56946546 |
| 51 | MP0003075_altered_response_to | 1.49567501 |
| 52 | MP0002132_abnormal_respiratory_system | 1.43195317 |
| 53 | MP0000490_abnormal_crypts_of | 1.41157405 |
| 54 | MP0003448_altered_tumor_morphology | 1.39808369 |
| 55 | MP0001873_stomach_inflammation | 1.38005080 |
| 56 | MP0003806_abnormal_nucleotide_metabolis | 1.36516865 |
| 57 | MP0002006_tumorigenesis | 1.34486299 |
| 58 | MP0000858_altered_metastatic_potential | 1.30337827 |
| 59 | MP0009764_decreased_sensitivity_to | 1.30174637 |
| 60 | MP0005310_abnormal_salivary_gland | 1.26352691 |
| 61 | MP0001851_eye_inflammation | 1.25438399 |
| 62 | MP0010307_abnormal_tumor_latency | 1.22419557 |
| 63 | MP0002933_joint_inflammation | 1.15798046 |
| 64 | MP0003763_abnormal_thymus_physiology | 1.13698345 |
| 65 | MP0008004_abnormal_stomach_pH | 1.09759320 |
| 66 | MP0003656_abnormal_erythrocyte_physiolo | 1.08305911 |
| 67 | MP0003828_pulmonary_edema | 1.06956670 |
| 68 | MP0005166_decreased_susceptibility_to | 0.98539767 |
| 69 | MP0000604_amyloidosis | 0.98080229 |
| 70 | MP0002998_abnormal_bone_remodeling | 0.97980261 |
| 71 | MP0000015_abnormal_ear_pigmentation | 0.97976094 |
| 72 | MP0003866_abnormal_defecation | 0.97212086 |
| 73 | MP0000703_abnormal_thymus_morphology | 0.95117417 |
| 74 | MP0009763_increased_sensitivity_to | 0.88139049 |
| 75 | MP0005390_skeleton_phenotype | 0.87032166 |
| 76 | MP0005076_abnormal_cell_differentiation | 0.85327708 |
| 77 | MP0001663_abnormal_digestive_system | 0.84859184 |
| 78 | MP0004381_abnormal_hair_follicle | 0.83656172 |
| 79 | MP0002019_abnormal_tumor_incidence | 0.83118093 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 0.80504079 |
| 81 | MP0003693_abnormal_embryo_hatching | 0.79792143 |
| 82 | MP0010352_gastrointestinal_tract_polyps | 0.78191516 |
| 83 | MP0005075_abnormal_melanosome_morpholog | 0.77587261 |
| 84 | MP0003566_abnormal_cell_adhesion | 0.76817676 |
| 85 | MP0000249_abnormal_blood_vessel | 0.76532624 |
| 86 | MP0002095_abnormal_skin_pigmentation | 0.74736584 |
| 87 | MP0005164_abnormal_response_to | 0.74317495 |
| 88 | MP0003186_abnormal_redox_activity | 0.73140830 |
| 89 | MP0005023_abnormal_wound_healing | 0.72112524 |
| 90 | MP0000371_diluted_coat_color | 0.71391225 |
| 91 | MP0009765_abnormal_xenobiotic_induced | 0.70679043 |
| 92 | MP0003453_abnormal_keratinocyte_physiol | 0.70405496 |
| 93 | MP0000920_abnormal_myelination | 0.67867641 |
| 94 | MP0000569_abnormal_digit_pigmentation | 0.67598422 |
| 95 | MP0002254_reproductive_system_inflammat | 0.67124622 |
| 96 | MP0008874_decreased_physiological_sensi | 0.67104477 |
| 97 | MP0008260_abnormal_autophagy | 0.65849802 |
| 98 | MP0008873_increased_physiological_sensi | 0.65667438 |
| 99 | MP0003690_abnormal_glial_cell | 0.63527135 |
| 100 | MP0003795_abnormal_bone_structure | 0.62851665 |
| 101 | MP0002138_abnormal_hepatobiliary_system | 0.59537967 |
| 102 | MP0003329_amyloid_beta_deposits | 0.59288553 |
| 103 | MP0005083_abnormal_biliary_tract | 0.58756360 |
| 104 | MP0000313_abnormal_cell_death | 0.57132367 |
| 105 | MP0004883_abnormal_blood_vessel | 0.56900874 |
| 106 | MP0004782_abnormal_surfactant_physiolog | 0.56443425 |
| 107 | MP0000598_abnormal_liver_morphology | 0.55587437 |
| 108 | MP0001986_abnormal_taste_sensitivity | 0.54647347 |
| 109 | MP0003045_fibrosis | 0.54597404 |
| 110 | MP0008007_abnormal_cellular_replicative | 0.53857551 |
| 111 | MP0003091_abnormal_cell_migration | 0.53433328 |
| 112 | MP0002277_abnormal_respiratory_mucosa | 0.52997252 |
| 113 | MP0000609_abnormal_liver_physiology | 0.52320334 |
| 114 | MP0002136_abnormal_kidney_physiology | 0.51785542 |
| 115 | MP0004858_abnormal_nervous_system | 0.50059164 |
| 116 | MP0002332_abnormal_exercise_endurance | 0.49741354 |
| 117 | MP0005319_abnormal_enzyme/_coenzyme | 0.49219289 |
| 118 | MP0005381_digestive/alimentary_phenotyp | 0.48281743 |
| 119 | MP0001542_abnormal_bone_strength | 0.47549345 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.01478033 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 6.24391485 |
| 3 | Eczematoid dermatitis (HP:0000976) | 6.13342732 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.27892003 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.88202371 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.86541017 |
| 7 | Myositis (HP:0100614) | 4.60830175 |
| 8 | Mediastinal lymphadenopathy (HP:0100721) | 4.26458337 |
| 9 | Chronic obstructive pulmonary disease (HP:0006510) | 4.18301405 |
| 10 | Obstructive lung disease (HP:0006536) | 4.18301405 |
| 11 | Vacuolated lymphocytes (HP:0001922) | 4.17163919 |
| 12 | Increased cerebral lipofuscin (HP:0011813) | 4.16447408 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 4.14954238 |
| 14 | Recurrent skin infections (HP:0001581) | 3.97371332 |
| 15 | Chronic otitis media (HP:0000389) | 3.81291556 |
| 16 | Recurrent fungal infections (HP:0002841) | 3.74029828 |
| 17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.69844404 |
| 18 | Cellulitis (HP:0100658) | 3.67713768 |
| 19 | Dysostosis multiplex (HP:0000943) | 3.51950993 |
| 20 | Orchitis (HP:0100796) | 3.45545601 |
| 21 | Gastrointestinal infarctions (HP:0005244) | 3.41690582 |
| 22 | Thrombocytosis (HP:0001894) | 3.39999766 |
| 23 | IgM deficiency (HP:0002850) | 3.35335720 |
| 24 | Gingivitis (HP:0000230) | 3.32942822 |
| 25 | Recurrent viral infections (HP:0004429) | 3.32722134 |
| 26 | Meningitis (HP:0001287) | 3.28557987 |
| 27 | Stomatitis (HP:0010280) | 3.22821024 |
| 28 | Interstitial pulmonary disease (HP:0006530) | 3.21432428 |
| 29 | Abnormality of glycolipid metabolism (HP:0010969) | 3.19540495 |
| 30 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.19540495 |
| 31 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.19540495 |
| 32 | Petechiae (HP:0000967) | 3.18976477 |
| 33 | Amyloidosis (HP:0011034) | 3.05938754 |
| 34 | Hypochromic microcytic anemia (HP:0004840) | 3.04083938 |
| 35 | Vasculitis (HP:0002633) | 3.00650228 |
| 36 | Glomerulonephritis (HP:0000099) | 2.95616465 |
| 37 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.95262834 |
| 38 | Mucopolysacchariduria (HP:0008155) | 2.95262834 |
| 39 | Keratoconjunctivitis (HP:0001096) | 2.92365848 |
| 40 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.87232483 |
| 41 | Urticaria (HP:0001025) | 2.86703957 |
| 42 | Episodic fever (HP:0001954) | 2.86556777 |
| 43 | Retrobulbar optic neuritis (HP:0100654) | 2.83223716 |
| 44 | Optic neuritis (HP:0100653) | 2.83223716 |
| 45 | Spontaneous hematomas (HP:0007420) | 2.81030502 |
| 46 | Autoimmune thrombocytopenia (HP:0001973) | 2.80066422 |
| 47 | Inflammation of the large intestine (HP:0002037) | 2.78098854 |
| 48 | Disinhibition (HP:0000734) | 2.74891001 |
| 49 | Loss of speech (HP:0002371) | 2.74170667 |
| 50 | Hypochromic anemia (HP:0001931) | 2.73793714 |
| 51 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.73312257 |
| 52 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.73312257 |
| 53 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.73312257 |
| 54 | Gastrointestinal inflammation (HP:0004386) | 2.71128631 |
| 55 | Colitis (HP:0002583) | 2.67836917 |
| 56 | Recurrent cutaneous fungal infections (HP:0011370) | 2.67784495 |
| 57 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.67784495 |
| 58 | Periodontitis (HP:0000704) | 2.65237449 |
| 59 | Agnosia (HP:0010524) | 2.65152137 |
| 60 | Thoracic kyphosis (HP:0002942) | 2.63818374 |
| 61 | Pustule (HP:0200039) | 2.61298814 |
| 62 | Nasal polyposis (HP:0100582) | 2.60631173 |
| 63 | Osteomyelitis (HP:0002754) | 2.58334595 |
| 64 | Hematochezia (HP:0002573) | 2.56627683 |
| 65 | Abnormality of the nasal mucosa (HP:0000433) | 2.53680090 |
| 66 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.49837624 |
| 67 | Axonal loss (HP:0003447) | 2.48510097 |
| 68 | Prolonged bleeding time (HP:0003010) | 2.48199189 |
| 69 | Basal ganglia calcification (HP:0002135) | 2.47835298 |
| 70 | Pulmonary embolism (HP:0002204) | 2.47404906 |
| 71 | Epistaxis (HP:0000421) | 2.45998703 |
| 72 | Anorexia (HP:0002039) | 2.43482458 |
| 73 | Hepatosplenomegaly (HP:0001433) | 2.42786126 |
| 74 | Leukocytosis (HP:0001974) | 2.41346483 |
| 75 | Pulmonary infiltrates (HP:0002113) | 2.35763959 |
| 76 | Recurrent pneumonia (HP:0006532) | 2.35248783 |
| 77 | Recurrent bronchitis (HP:0002837) | 2.35157202 |
| 78 | Chest pain (HP:0100749) | 2.34245982 |
| 79 | T lymphocytopenia (HP:0005403) | 2.33939174 |
| 80 | Increased IgM level (HP:0003496) | 2.33404502 |
| 81 | Abnormality of T cell physiology (HP:0011840) | 2.31810891 |
| 82 | Abnormal platelet function (HP:0011869) | 2.29800934 |
| 83 | Impaired platelet aggregation (HP:0003540) | 2.29800934 |
| 84 | Abnormality of iron homeostasis (HP:0011031) | 2.27242771 |
| 85 | Increased IgE level (HP:0003212) | 2.26937383 |
| 86 | Arterial thrombosis (HP:0004420) | 2.26138942 |
| 87 | Gingival bleeding (HP:0000225) | 2.24406429 |
| 88 | Mutism (HP:0002300) | 2.22668884 |
| 89 | Recurrent lower respiratory tract infections (HP:0002783) | 2.20255539 |
| 90 | Abnormality of T cell number (HP:0011839) | 2.20018338 |
| 91 | Premature loss of primary teeth (HP:0006323) | 2.19706683 |
| 92 | Hemoptysis (HP:0002105) | 2.19692197 |
| 93 | Panhypogammaglobulinemia (HP:0003139) | 2.18549199 |
| 94 | Peritonitis (HP:0002586) | 2.16923646 |
| 95 | Microcytic anemia (HP:0001935) | 2.16599044 |
| 96 | Abnormality of the thoracic spine (HP:0100711) | 2.16539373 |
| 97 | J-shaped sella turcica (HP:0002680) | 2.14949383 |
| 98 | Abnormality of the pleura (HP:0002103) | 2.13940764 |
| 99 | Hypergammaglobulinemia (HP:0010702) | 2.13025486 |
| 100 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.10688171 |
| 101 | Gangrene (HP:0100758) | 2.10453710 |
| 102 | Abnormality of the prostate (HP:0008775) | 2.09654370 |
| 103 | Albinism (HP:0001022) | 2.08491736 |
| 104 | Abnormality of the lumbar spine (HP:0100712) | 2.05339366 |
| 105 | Skin ulcer (HP:0200042) | 2.05134357 |
| 106 | Abnormality of T cells (HP:0002843) | 2.02529667 |
| 107 | Upper motor neuron abnormality (HP:0002127) | 2.01230039 |
| 108 | Polyneuropathy (HP:0001271) | 2.00919397 |
| 109 | Reduced antithrombin III activity (HP:0001976) | 2.00109556 |
| 110 | Lymphopenia (HP:0001888) | 1.98467305 |
| 111 | Sepsis (HP:0100806) | 1.98249398 |
| 112 | Glomerulopathy (HP:0100820) | 1.97694681 |
| 113 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.96722126 |
| 114 | Eosinophilia (HP:0001880) | 1.94540688 |
| 115 | Poor head control (HP:0002421) | 1.93926404 |
| 116 | Malnutrition (HP:0004395) | 1.93702863 |
| 117 | Abnormality of the peritoneum (HP:0002585) | 1.92742771 |
| 118 | Gastrointestinal stroma tumor (HP:0100723) | 1.91708326 |
| 119 | Polycythemia (HP:0001901) | 1.91438355 |
| 120 | Acne (HP:0001061) | 1.90951503 |
| 121 | Agammaglobulinemia (HP:0004432) | 1.90636841 |
| 122 | Purpura (HP:0000979) | 1.90202177 |
| 123 | Restrictive lung disease (HP:0002091) | 1.88800789 |
| 124 | Granulocytopenia (HP:0001913) | 1.88403889 |
| 125 | Increased serum ferritin (HP:0003281) | 1.87554181 |
| 126 | Encephalitis (HP:0002383) | 1.85601905 |
| 127 | Keratoconjunctivitis sicca (HP:0001097) | 1.85205220 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.67687265 |
| 2 | BLK | 3.43897494 |
| 3 | IRAK4 | 3.41251488 |
| 4 | KIT | 3.24407046 |
| 5 | RIPK4 | 2.90219573 |
| 6 | ERN1 | 2.88041962 |
| 7 | TBK1 | 2.87675387 |
| 8 | TYK2 | 2.75144580 |
| 9 | CSF1R | 2.46213679 |
| 10 | TNK2 | 2.38352512 |
| 11 | IRAK3 | 2.36321406 |
| 12 | PRPF4B | 2.33902169 |
| 13 | FES | 2.21988409 |
| 14 | TAOK1 | 2.13909666 |
| 15 | BTK | 2.13034623 |
| 16 | MAP3K14 | 1.93646918 |
| 17 | TGFBR2 | 1.87796464 |
| 18 | TEC | 1.84374403 |
| 19 | PIM2 | 1.82760414 |
| 20 | IKBKE | 1.81160420 |
| 21 | MAP2K3 | 1.78408826 |
| 22 | ZAP70 | 1.76885390 |
| 23 | IKBKB | 1.68750375 |
| 24 | SYK | 1.66862157 |
| 25 | FLT3 | 1.65393685 |
| 26 | NME2 | 1.57356221 |
| 27 | JAK3 | 1.57124508 |
| 28 | EPHB1 | 1.54871436 |
| 29 | CSK | 1.46234051 |
| 30 | TAOK3 | 1.45699071 |
| 31 | HCK | 1.41849194 |
| 32 | SIK3 | 1.40943624 |
| 33 | TAOK2 | 1.40358783 |
| 34 | STK10 | 1.38741270 |
| 35 | PKN2 | 1.34507103 |
| 36 | MATK | 1.34162710 |
| 37 | RPS6KA4 | 1.30615419 |
| 38 | LRRK2 | 1.27845338 |
| 39 | TRIB3 | 1.27193666 |
| 40 | SCYL2 | 1.26391882 |
| 41 | LYN | 1.24667444 |
| 42 | CLK1 | 1.17960624 |
| 43 | EEF2K | 1.10159535 |
| 44 | GRK6 | 1.10141809 |
| 45 | JAK1 | 1.09952755 |
| 46 | PAK4 | 1.09228892 |
| 47 | LCK | 1.08354507 |
| 48 | TXK | 1.07518000 |
| 49 | KSR2 | 1.03142569 |
| 50 | MARK2 | 1.02427298 |
| 51 | MAP3K11 | 1.02209847 |
| 52 | TESK2 | 1.01799133 |
| 53 | PIM1 | 1.00531190 |
| 54 | CAMKK2 | 1.00265443 |
| 55 | FGR | 0.99096220 |
| 56 | GRK7 | 0.97968690 |
| 57 | EIF2AK3 | 0.97680204 |
| 58 | PRKD2 | 0.95052512 |
| 59 | KDR | 0.91727902 |
| 60 | MAP3K13 | 0.91717457 |
| 61 | CDC42BPA | 0.89714591 |
| 62 | MAP3K10 | 0.88588044 |
| 63 | IRAK2 | 0.84305534 |
| 64 | SMG1 | 0.82830347 |
| 65 | JAK2 | 0.82670269 |
| 66 | PDK1 | 0.79908578 |
| 67 | PDPK1 | 0.79325256 |
| 68 | IRAK1 | 0.79046922 |
| 69 | BMPR2 | 0.72393963 |
| 70 | MAPK4 | 0.71316082 |
| 71 | CHUK | 0.71019501 |
| 72 | WEE1 | 0.69484123 |
| 73 | ACVR1B | 0.69019659 |
| 74 | MAPK12 | 0.64503730 |
| 75 | ITK | 0.64496402 |
| 76 | ABL2 | 0.63356174 |
| 77 | CAMK1D | 0.63180427 |
| 78 | SIK1 | 0.62280232 |
| 79 | FYN | 0.61463844 |
| 80 | TGFBR1 | 0.60413519 |
| 81 | RPS6KA6 | 0.60091044 |
| 82 | PTK6 | 0.58169269 |
| 83 | NEK9 | 0.58044094 |
| 84 | MAP3K3 | 0.57039667 |
| 85 | TRPM7 | 0.57031710 |
| 86 | STK16 | 0.56643305 |
| 87 | MAPK7 | 0.55954852 |
| 88 | SIK2 | 0.54895820 |
| 89 | MAP3K12 | 0.54567427 |
| 90 | PRKG2 | 0.54455954 |
| 91 | DAPK2 | 0.52130549 |
| 92 | MAP3K7 | 0.51815530 |
| 93 | MARK3 | 0.50887153 |
| 94 | ABL1 | 0.50242953 |
| 95 | RPS6KC1 | 0.49841636 |
| 96 | RPS6KL1 | 0.49841636 |
| 97 | NEK2 | 0.49687409 |
| 98 | MAP3K8 | 0.49154897 |
| 99 | PRKCD | 0.49106992 |
| 100 | HIPK2 | 0.48388652 |
| 101 | MAPKAPK2 | 0.48078838 |
| 102 | MAP2K6 | 0.47689527 |
| 103 | MAP2K4 | 0.46048168 |
| 104 | MOS | 0.46033030 |
| 105 | DYRK1B | 0.44762221 |
| 106 | EIF2AK2 | 0.44212153 |
| 107 | STK4 | 0.44069968 |
| 108 | EGFR | 0.42618743 |
| 109 | PRKCQ | 0.42428805 |
| 110 | CDK4 | 0.42371473 |
| 111 | TTN | 0.42217290 |
| 112 | CAMKK1 | 0.40415765 |
| 113 | STK11 | 0.39716076 |
| 114 | CDK6 | 0.38995262 |
| 115 | VRK1 | 0.38972032 |
| 116 | CDK19 | 0.38839230 |
| 117 | ALK | 0.37261373 |
| 118 | MAP3K1 | 0.36861953 |
| 119 | RAF1 | 0.35458252 |
| 120 | SGK3 | 0.34639120 |
| 121 | MAP3K6 | 0.34540730 |
| 122 | MAP3K5 | 0.34370499 |
| 123 | NLK | 0.34005850 |
| 124 | EIF2AK1 | 0.33495170 |
| 125 | TLK1 | 0.33445225 |
| 126 | PTK2B | 0.31790921 |
| 127 | YES1 | 0.31628221 |
| 128 | MAP3K2 | 0.31419316 |
| 129 | RIPK1 | 0.31330134 |
| 130 | RPS6KA2 | 0.30655134 |
| 131 | TESK1 | 0.29846494 |
| 132 | EPHA3 | 0.29689530 |
| 133 | DAPK1 | 0.29560687 |
| 134 | DYRK3 | 0.29086539 |
| 135 | RET | 0.28416347 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.54839112 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.99473132 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.59650014 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.58052556 |
| 5 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.46387669 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.43565422 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.39780457 |
| 8 | Pertussis_Homo sapiens_hsa05133 | 2.27996988 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.18631613 |
| 10 | Lysosome_Homo sapiens_hsa04142 | 2.15688084 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.14459412 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 2.10347696 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 2.07421669 |
| 14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.96524836 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.95479157 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.91171697 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.85737448 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.83359786 |
| 19 | Malaria_Homo sapiens_hsa05144 | 1.82326232 |
| 20 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.80468736 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.73063236 |
| 22 | Shigellosis_Homo sapiens_hsa05131 | 1.71529005 |
| 23 | DNA replication_Homo sapiens_hsa03030 | 1.71036787 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.60539452 |
| 25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.59939950 |
| 26 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.59885274 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.55667271 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.54426530 |
| 29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.53949266 |
| 30 | Asthma_Homo sapiens_hsa05310 | 1.53588931 |
| 31 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.52900274 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.52525173 |
| 33 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.48289221 |
| 34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.47059789 |
| 35 | Salmonella infection_Homo sapiens_hsa05132 | 1.45794055 |
| 36 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.45624843 |
| 37 | Phagosome_Homo sapiens_hsa04145 | 1.41421411 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.38805532 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.36698961 |
| 40 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.33647159 |
| 41 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.29652199 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.29022041 |
| 43 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.26032570 |
| 44 | Ribosome_Homo sapiens_hsa03010 | 1.25930231 |
| 45 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.25148831 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 1.20352254 |
| 47 | Allograft rejection_Homo sapiens_hsa05330 | 1.07929040 |
| 48 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.07674920 |
| 49 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.07577869 |
| 50 | * Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.02116005 |
| 51 | Platelet activation_Homo sapiens_hsa04611 | 0.98063669 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.96962194 |
| 53 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.94820298 |
| 54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.94187631 |
| 55 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.94073106 |
| 56 | Base excision repair_Homo sapiens_hsa03410 | 0.90814295 |
| 57 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.90070283 |
| 58 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.89484683 |
| 59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.85496483 |
| 60 | Hepatitis C_Homo sapiens_hsa05160 | 0.85447913 |
| 61 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82639965 |
| 62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.81796914 |
| 63 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.80287627 |
| 64 | Mismatch repair_Homo sapiens_hsa03430 | 0.77993106 |
| 65 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77003071 |
| 66 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.76578658 |
| 67 | Viral myocarditis_Homo sapiens_hsa05416 | 0.75574334 |
| 68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.70228324 |
| 69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.70029116 |
| 70 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.67291785 |
| 71 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.66882308 |
| 72 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65490213 |
| 73 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.65006690 |
| 74 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.61625919 |
| 75 | Amoebiasis_Homo sapiens_hsa05146 | 0.60266302 |
| 76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59814467 |
| 77 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.59621841 |
| 78 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59323312 |
| 79 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.58568984 |
| 80 | Homologous recombination_Homo sapiens_hsa03440 | 0.57425622 |
| 81 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.56852753 |
| 82 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.55000475 |
| 83 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.54655061 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53241381 |
| 85 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.53225191 |
| 86 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51976095 |
| 87 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.51630487 |
| 88 | Bladder cancer_Homo sapiens_hsa05219 | 0.50776993 |
| 89 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.49890050 |
| 90 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.45485652 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45123025 |
| 92 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.44872847 |
| 93 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44620947 |
| 94 | Proteasome_Homo sapiens_hsa03050 | 0.43847933 |
| 95 | Prion diseases_Homo sapiens_hsa05020 | 0.43777047 |
| 96 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.43341438 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43228172 |
| 98 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41069021 |
| 99 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.40310554 |
| 100 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.39590059 |
| 101 | Endocytosis_Homo sapiens_hsa04144 | 0.39334613 |
| 102 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38372002 |
| 103 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.37920927 |
| 104 | Sulfur relay system_Homo sapiens_hsa04122 | 0.37512534 |
| 105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37004524 |
| 106 | Insulin resistance_Homo sapiens_hsa04931 | 0.36159762 |
| 107 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.35586928 |
| 108 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35294936 |
| 109 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35002416 |
| 110 | Colorectal cancer_Homo sapiens_hsa05210 | 0.34752549 |
| 111 | Endometrial cancer_Homo sapiens_hsa05213 | 0.34701639 |
| 112 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.33909102 |
| 113 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.33295666 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32824566 |
| 115 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32606404 |
| 116 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.32142171 |
| 117 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.32025978 |
| 118 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.31745670 |
| 119 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.31402456 |
| 120 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.31246816 |
| 121 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.30154640 |
| 122 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.29178760 |

